Advertisement

Topics

Latest "Biopure Corporation" News Stories

22:22 EST 20th February 2018 | BioPortfolio

Here are the most relevant search results for "Biopure Corporation" found in our extensive news archives from over 250 global news sources.

More Information about Biopure Corporation on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Biopure Corporation for you to read. Along with our medical data and news we also list Biopure Corporation Clinical Trials, which are updated daily. BioPortfolio also has a large database of Biopure Corporation Companies for you to search.

Showing "Biopure Corporation" News Articles 1–25 of 330

Relevant

BioPure Q-Clamp is compatible with a wide range of connector geometries


CombiMatrix Corporation Reminds Shareholders to Vote "FOR" the Merger With Invitae Corporation

IRVINE, Calif., Nov. 02, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX) ("CombiMatrix" or the "Company"), a family health molecular diagnostics company specializing in DNA-based reproductive health and pediatric testing services, reminds its shareholders to vote “FOR” the proposed merger with Invitae Corporation as described in the Company’s proxy statement/prospectus fo...

CombiMatrix Corporation Stockholders Approve Merger Agreement With Invitae Corporation

IRVINE, Calif., Nov. 10, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX) ("CombiMatrix" or the "Company"), a family health molecular diagnostics company specializing in DNA-based reproductive health and pediatric testing services, announced today that, based upon the final vote count for the Company’s Special Meeting of Stockholders held today, a majority of its stockholders ...


Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend CombiMatrix Corporation Shareholders Vote "FOR" the Proposed Merger with Invitae Corporation

IRVINE, Calif., Nov. 01, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX) ("CombiMatrix" or the "Company"), a family health molecular diagnostics company specializing in DNA-based reproductive health and pediatric testing services, today announced that Institutional Shareholder Services Inc. (ISS) and Glass, Lewis & Co., LLC (Glass Lewis) have both recommended that CombiMatr...

Single-use Tri-Clamp provides quick and qualified process security

BioPure s QClamp is a new sanitary Tri-Clamp for single-use fluid path applications

Orion Corporation: Managers' transactions - Hilpi Rautelin

ORION CORPORATION      MANAGERS' TRANSACTIONS 1st of November 2017 at 22.15 EET              Orion Corporation: Managers' transactions - Hilpi Rautelin Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their ...

Orion Corporation: Managers' transactions - Westerlund Riikka

ORION CORPORATION         MANAGERS' TRANSACTIONS 27 DECEMBER 2017 at 9.45 EET Orion Corporation: Managers' transactions - Westerlund Riikka Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associa...

Orion Corporation: Managers' transactions - Huhta-Koivisto Eemeli

ORION CORPORATION         MANAGERS' TRANSACTIONS 18 DECEMBER 2017 at 17.15 EET              Orion Corporation: Managers' transactions - Huhta-Koivisto Eemeli Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by...

Orion Corporation: Managers' transactions - Huhta-Koivisto Kalle

ORION CORPORATION   MANAGERS' TRANSACTIONS 18 DECEMBER 2017 at 15.50 EET Orion Corporation: Managers' transactions - Huhta-Koivisto Kalle Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated p...

Orion Corporation: Managers' transactions - Huhta-Koivisto Tero

ORION CORPORATION      MANAGERS' TRANSACTIONS 18 DECEMBER 2017 at 16.00 EET Orion Corporation: Managers' transactions - Huhta-Koivisto Tero Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associa...

Orion Corporation: Managers' transactions - Ylppö Jukka

ORION CORPORATION         MANAGERS' TRANSACTIONS 03 JANUARY 2018 at 15.10 EET              Orion Corporation: Managers' transactions - Ylppö Jukka Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and t...

Orion Corporation: Managers' transactions - Huhta-Koivisto Esko kuolinpesä

ORION CORPORATION      MANAGERS' TRANSACTIONS 18 DECEMBER 2017 at 15.45 EET              Orion Corporation: Managers' transactions - Huhta-Koivisto Esko kuolinpesä Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made b...

Stryker declares a $0.47 per share quarterly dividend

Kalamazoo, Michigan - February 7, 2018 - Stryker Corporation (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.47 per share payable on April 30, 2018 to shareholders of record at the close of business on March 29, 2018, representing an increase of approximately 11% versus the prior year and unchanged from the previous quarter.  Stryker is on...

Crown Bioscience Announces Merger with JSR Corporation

SAN DIEGO, Dec. 21, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE:ticker 6554) and a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research, announced yesterday that they will merge with and become a fully owned sub...

Vestaron Corporation is Named in the 2018 Global Cleantech 100

KALAMAZOO, Mich., Jan. 29, 2018 (GLOBE NEWSWIRE) -- Vestaron Corporation, a leading developer of peptide-based bioinsecticides, today announced it was named in the prestigious 2018 Global Cleantech 100, produced by CTG (Cleantech Group), whose research and events services keep its audiences and clients in touch with emerging trends, leading innovation companies and all key players in sustaina...

Gregory B. Brown M.D. Appointed to the Board of Directors of Cambrex Corporation

EAST RUTHERFORD, N.J., Nov. 03, 2017 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced that Gregory B. Brown, M.D. was appointed to the Company’s Board of Directors on October 31, 2017, and will serve on the Board’s Audit and Regulatory Affairs Committees.  Dr. Brown...

Mitsubishi Tanabe Pharma Corporation Completes Acquisition of NeuroDerm

REHOVOT, Israel, Oct. 18, 2017 (GLOBE NEWSWIRE) -- NeuroDerm Ltd. (Nasdaq:NDRM), a clinical stage pharmaceutical company developing drug-device combinations for central nervous system (CNS) disorders, announced today the completion of the previously announced acquisition of NeuroDerm by Mitsubishi Tanabe Pharma Corporation (TSE Code: 4508), a publicly traded company on the Tokyo Stock Exchang...

Geron Corporation Reports Third Quarter 2017 Financial Results

MENLO PARK, Calif., Nov. 01, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today reported financial results for the three and nine months ended September 30, 2017. For the third quarter of 2017, the company reported a net loss of $6.9 million, or $0.04 per share, compared to $3.6 million, or $0.02 per share, for the comparable 2016 period. Net loss for the first nine months o...

CombiMatrix Corporation Reports Third Quarter 2017 Financial and Operating Results

IRVINE, Calif., Nov. 06, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a family health molecular diagnostics company specializing in DNA-based reproductive health and pediatric testing services, announces financial and operating results for the three and nine months ended September 30, 2017. 

ICC International Cannabis Corporation Provides Cannabinoid Extract Business Segment Update

Highlights:

Advanced Proteome Therapeutics and ImmunoBiochem Corporation enter into a Collaboration and Option Agreement

VANCOUVER, British Columbia and TORONTO, Feb. 07, 2018 (GLOBE NEWSWIRE) -- Advanced Proteome Therapeutics Corporation (APC), a therapeutics discovery and development company, and ImmunoBiochem Corporation, today announced entering into a Collaboration and Option agreement to develop superior antibody-drug conjugates.  The companies will evaluate the prospect of combining ImmunoBiochem’s pr...

ImmuCell Corporation Announces Pricing of $3 Million Public Offering of Common Shares

PORTLAND, Maine, Dec. 19, 2017 (GLOBE NEWSWIRE) -- ImmuCell Corporation (“ImmuCell” or the “Company”) (Nasdaq:ICCC), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy and beef cattle, today announced an underwritten public offering of 417,807 shares of common stock at a...

ImmuCell Corporation Announces Closing of $3 Million Public Offering of Common Stock

PORTLAND, Maine, Dec. 21, 2017 (GLOBE NEWSWIRE) -- ImmuCell Corporation (“ImmuCell” or the “Company”) (Nasdaq:ICCC), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy and beef cattle, today announced the closing of a previously announced underwritten public offering o...

NeuroDerm Shareholders Approve Proposed Acquisition by Mitsubishi Tanabe Pharma Corporation

REHOVOT, Israel, Sept. 12, 2017 (GLOBE NEWSWIRE) -- NeuroDerm Ltd. (Nasdaq:NDRM), a clinical stage pharmaceutical company developing drug-device combinations for central nervous system (CNS) disorders, announced that at NeuroDerm’s extraordinary general meeting of shareholders held today, NeuroDerm shareholders voted to approve the previously announced acquisition by Mitsubishi Tanabe Pharm...

International Stem Cell Corporation is Valued at $33 Million Market Value by Edison Investment Research

CARLSBAD, Calif., Jan. 22, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company developing novel stem cell-based therapies and biomedical products, announced today that it has been valued at $33 million, up from $27 million in May 2017, by Edison Investment Research (“Edison”), a world-...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks